Rep. Diana DeGette (D-Colo.) is considering a drug price bill that specifically addresses high insulin prices.
She told Bloomberg Law in an interview June 19 she was waiting to see how lawmakers would fair in drafting a drug price bill that was “more far ranging,” but “so far they haven’t really come up with one. So we may move ahead with just an insulin-based bill,” she said, referring to herself and Rep. Tom Reed (R-N.Y.).
Insulin prices have served as...
For more stories, analysis and expertiseOR Request Trial